Med Tech Buying Spree Dwindles As Abbott Heightens “Internal Focus”
This article was originally published in The Gray Sheet
Executive Summary
Abbott Labs is toughening its merger-and-acquisition criteria so it can focus on nourishing a series of device sector investments made over the past three years